Initial RCT of a distress tolerance treatment for individuals with substance use disorders.
Initial RCT of a distress tolerance treatment for individuals with substance use disorders.
复制标题
DOI：
10.1016/j.drugalcdep.2011.09.012
复制
发表时间：
2012-04-01
影响因子：
4.2
通讯作者：
Lejuez, C. W.
中科院分区：
文献类型：
--
作者：
Bornovalova, Marina A.;Gratz, Kim L.;Daughters, Stacey B.;Hunt, Elizabeth D.;Lejuez, C. W.
心理困扰耐受性，即在经历心理困扰时坚持目标导向活动的能力，与不良的药物使用治疗结果相关，包括药物和酒精治疗的退出和复发。目前的研究考察了是否一个简短的痛苦耐受干预是专门开发的辅助治疗的病人在住宅药物滥用治疗显示出有效的改善病人的痛苦耐受。76名在住宅物质使用治疗机构接受治疗的个体，在实验室的痛苦耐受性测量中被指证为低痛苦耐受性，随机分为三种情况：照常治疗（TAU），六次支持性咨询（SC），或六次新型痛苦耐受性治疗，改善痛苦耐受性技能（SIDI）。在基线时对患者进行DSM-IV精神诊断、DSM-IV物质使用障碍、痛苦耐受性和抑郁症状的评估。治疗后再次对患者进行评估。治疗后还评估了治疗联盟、治疗期望和可信度。接受SIDI治疗的患者（n = 28）比SC （n = 24）和TAU参与者（n = 24）在痛苦耐受实验室测量方面有显著改善，即使在控制负面影响（以抑郁形式）的变化时也是如此。此外，与SC和TAU患者相比，SIDI患者达到临床显著改善的比例更高。本研究支持SIDI在改善目前接受住院药物使用治疗的药物和酒精使用障碍患者的痛苦耐受水平方面的功效。SIDI似乎是在住院药物使用设施内使用的一种简短而可行的干预措施。
Psychological distress tolerance, the ability to persist in goal directed activity when experiencing psychological distress, is associated with poor substance use treatment outcomes including drug and alcohol treatment dropout and relapse. The current study examines if a brief distress tolerance intervention that was specifically developed as an adjunctive treatment for patients in residential substance abuse treatment shows efficacy in improving the patients’ distress tolerance. Seventy-six individuals who were receiving treatment at a residential substance use treatment facility and indexed low distress tolerance on laboratory distress tolerance measures were randomized into three conditions: Treatment-As-Usual (TAU), six sessions of Supportive Counseling (SC), or six sessions of the novel distress tolerance treatment, Skills for Improving Distress Intolerance (SIDI). Patients were assessed at baseline for DSM-IV psychiatric diagnoses, DSM-IV substance use disorders, distress tolerance, and depressive symptoms. Patients were again assessed at posttreatment. Therapeutic alliance and treatment expectancies and credibility were also assessed at posttreatment. Patients who received SIDI (n = 28) evidenced significantly greater improvements than SC (n = 24) and TAU participants (n = 24) on the distress tolerance laboratory measures, even when controlling for changes in negative affect (in the form of depression). Additionally, a higher percentage of patients in SIDI reached clinically significant improvement compared to patients in SC and TAU. This study supports the efficacy of SIDI in improving distress tolerance levels among individuals with drug and alcohol use disorders currently receiving residential substance use treatment. SIDI appears to be a brief and feasible intervention for use within inpatient substance use facilities.
登录
查看更多内容
影响因子：
3.7
作者：
Keough, Meghan E.;Riccardi, Christina J.;Timpano, Kiara R.;Mitchell, Melissa A.;Schmidt, Norman B.
通讯作者：
Schmidt, Norman B.
影响因子：
7.3
作者：
Gratz, Kim L.;Rosenthal, M. Zachary;Gunderson, John G.
通讯作者：
Gunderson, John G.
影响因子：
4.1
作者：
Daughters, Stacey B.;Reynolds, Elizabeth K.;Lejuez, C. W.
通讯作者：
Lejuez, C. W.
影响因子：
5.9
作者：
JACOBSON, NS;TRUAX, P
通讯作者：
TRUAX, P
影响因子：
2.4
作者：
Daughters, Stacey B.;Lejuez, C. W.
通讯作者：
Lejuez, C. W.